VitaNova Life Sciences (VNOV) Net Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Net Margin came in at 0.98% in Q2 2026, down 3999.0% YoY from 0.03% in Q2 2025, and up 115.73% on a QoQ basis from 6.25% in Q1 2026.
VitaNova Life Sciences (VNOV) Net Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 7 years of Net Margin data on file, last reported at 0.98% in Q2 2026.
- Quarterly Net Margin fell 3999.0% year-over-year to 0.98% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 1.23% (down 3319.0% YoY) and the FY2026 annual result came in at 1.23%, down 3319.0% from the prior year.
- Net Margin rose to 0.98% in Q2 2026, from 6.25% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 40.98% in Q2 2025 to a low of 245.77% in Q1 2023.
- A 5-year average of 21.53% and a median of 9.78% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin tumbled 27549 bps — and 2024, when it surged 26856 bps.
- Tracing VNOV's Net Margin over 5 years: stood at 26.01% in 2022, then sank by 662 bps to 146.17% in 2023, then surged by 108 bps to 11.18% in 2024, then retreated by 25 bps to 8.38% in 2025, then slumped by 88 bps to 0.98% in 2026.
- The last three Net Margin figures came in at 0.98% (Q2 2026), 6.25% (Q1 2026), and 8.38% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 0.98% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 0.92% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 0.63% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 2.98% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -109.73% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -14.52% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -1.57% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -32.06% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 0.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.98% |
| Jan 31, 2026 | -6.25% |
| Oct 31, 2025 | 8.38% |
| Jul 31, 2025 | -44.56% |
| Apr 30, 2025 | 40.98% |
| Jan 31, 2025 | 23.67% |
| Oct 31, 2024 | 11.18% |
| Jul 31, 2024 | -50.90% |
| Apr 30, 2024 | 30.83% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -245.77% |
| Oct 31, 2022 | 26.01% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | -59.57% |
| Jan 31, 2022 | 29.72% |
| Oct 31, 2021 | 33.35% |
| Jul 31, 2017 | 116.47% |